0.5915 ? 0.002379 (0.40%)
Volume: 238,737 @04/14/20 4:10:20 PM EDT
Bid Ask Day's Range
0.578 0.6169 0.58 - 0.66
IPATF Detailed Quote
Recent IPA News
- Form D - Notice of Exempt Offering of Securities • Edgar (US Regulatory) • 07/30/2024 05:57:45 PM
- ImmunoPrecise Antibodies (IPA) publie ses résultats financiers et ses mises à jour commerciales pour le quatrième trimestre et l'exercice 2024 • Business Wire • 07/30/2024 01:05:00 PM
- Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)] • Edgar (US Regulatory) • 07/29/2024 12:38:58 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 07/29/2024 12:35:02 PM
- ImmunoPrecise Antibodies (IPA) Reports Financial Results and Business Updates for Fourth Quarter and Full Fiscal Year 2024 • Business Wire • 07/29/2024 12:30:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 07/24/2024 01:55:46 AM
- ImmunoPrecise Antibodies to Reschedule Financial Results and Recent Business Highlights Report for Fourth Quarter and Fiscal Year-End 2024 • Business Wire • 07/23/2024 11:30:00 PM
- ImmunoPrecise annonce un accord de financement avec Yorkville Advisors Global, LP d'un montant en capital global de 3,0 millions USD de débentures convertibles • Business Wire • 07/17/2024 12:22:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 07/17/2024 01:41:01 AM
- ImmunoPrecise Announces Financing Agreement with Yorkville Advisors Global, LP of up to $3.0 Million Aggregate Principal Amount of Convertible Debentures • Business Wire • 07/17/2024 12:01:00 AM
- IPA présentera le 25 juillet 2024 ses résultats financiers et les faits saillants récents de ses activités pour le quatrième trimestre et l'exercice financier 2024 • Business Wire • 07/16/2024 11:26:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 07/15/2024 12:32:43 PM
- IPA to Report Financial Results and Recent Business Highlights for Fourth Quarter and Fiscal Year End 2024 on July 25th, 2024 • Business Wire • 07/15/2024 12:31:00 PM
- ImmunoPrecise nomme Kristin Taylor au poste de directeur financier • Business Wire • 06/27/2024 10:27:00 PM
- ImmunoPrecise Appoints Kristin Taylor as Chief Financial Officer • Business Wire • 06/27/2024 12:01:00 PM
- BioStrand, filiale d’IPA, et PGxAI annoncent un accord de collaboration stratégique visant à développer à l’aide de LENSai™ un modèle d’IA d’avant-garde pour les recommandations pharmacogénomiques • Business Wire • 06/25/2024 11:55:00 PM
- IPA’s Subsidiary BioStrand and PGxAI Announce Strategic Collaboration to Develop First-In-Class AI Model for Pharmacogenomics Recommendations Using LENSai™ • Business Wire • 06/25/2024 11:02:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 06/12/2024 05:01:33 PM
- BioStrand, filiale d’ImmunoPrecise Antibodies Ltd., reçoit le prestigieux prix Impact 2024 pour sa technologie LENSai™ révolutionnaire • Business Wire • 06/12/2024 11:00:00 AM
- ImmunoPrecise Antibodies Ltd. Subsidiary BioStrand Receives Prestigious 2024 Impact Award for Groundbreaking LENSai™ Technology • Business Wire • 06/12/2024 11:00:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 06/10/2024 06:23:10 PM
- BioStrand, filiale d’ImmunoPrecise Antibodies, annonce la disponibilité commerciale immédiate de son logiciel révolutionnaire doté d’une interface personnalisable pour la découverte de médicaments optimisée par l’IA • Business Wire • 06/10/2024 03:34:00 PM
- BioStrand, ImmunoPrecise Antibodies’ Subsidiary, Announces Immediate Commercial Offering of Groundbreaking Software with Customizable Interface for AI-Driven Drug Discovery • Business Wire • 06/10/2024 11:15:00 AM
- La filiale d’IPA, BioStrand, annonce un LLM avancé pour les dossiers de santé électroniques • Business Wire • 06/04/2024 09:01:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 06/04/2024 08:11:55 PM
Kona Gold Beverages, Inc. Announces Strategic Initiatives and Corporate Direction Changes • KGKG • Aug 2, 2024 2:00 PM
POET and Luxshare Tech Expand Product Offerings for Artificial Intelligence Networks • POET • Aug 1, 2024 9:28 AM
Management Discusses Financial Filings of Global Arena Holding Inc., for 10-K 2023 and 10-Q, 1st Quarter 2024 • GAHC • Aug 1, 2024 9:14 AM
VAYK Announces LOI to Acquire $1 Million Home Service Company to Support Airbnb Business • VAYK • Aug 1, 2024 9:00 AM
Duane Forrester Joins INDEXR as SVP of Search • MONI • Jul 31, 2024 11:46 AM
Lingerie Fighting Championships Help Fulfill Death-Bed Promise With First Major Motion Picture • BOTY • Jul 31, 2024 9:00 AM